Tag: cTACE

TACE

Conventional transarterial chemoembolization more cost-effective than drug-eluting embolic TACE

Compared with doxorubicin-loaded drug-eluting embolic transarterial chemoembolization (DEE-TACE), conventional transarterial chemoembolization (cTACE) yielded a higher number of quality-adjusted life years (QALY) at a lower...
Interventional News for specialists

Coalition of cTACE and immunotherapy: Expanding the horizons of interventional oncology

This article is sponsored by Guerbet. immunotherapy  Preliminary evidence suggests that combining conventional transarterial chemoembolization (cTACE) with immunotherapy could be beneficial to patients with unresectable...

Automatic characterisation of Lipiodol deposition after cTACE may make predictions about...

Automatic characterisation of Lipiodol (Guerbet) deposition is feasible, workflow efficient, and improves consistency across patients, argued Sophie Stark (Yale School of Medicine, New Haven,...

Vectorio®: Efficacy and safety for improved cTACE mixing and delivery

This educational supplement, sponsored by Guerbet, is intended for readers in the EU only. Guerbet obtained the CE mark for its conventional transarterial chemoembolization...

Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE

Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...

Guerbet announces CE mark for Vectorio mixing and injection system for...

Guerbet has announced obtaining the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio. Designed in collaboration with interventional radiologists worldwide,...

Thailand FDA approves new indication for Guerbet’s Lipiodol Ultra-Fluide

Guerbet has announced that the Thailand FDA has given approval of a new indication for Lipiodol Ultra-Fluide for selective hepatic intra-arterial injection for visualisation,...